0001209191-19-012023.txt : 20190221
0001209191-19-012023.hdr.sgml : 20190221
20190221163217
ACCESSION NUMBER: 0001209191-19-012023
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190220
FILED AS OF DATE: 20190221
DATE AS OF CHANGE: 20190221
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Breeden Richard C
CENTRAL INDEX KEY: 0001300622
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37614
FILM NUMBER: 19622280
MAIL ADDRESS:
STREET 1: 100 SOUTH WACKER
STREET 2: SUITE 1800
CITY: CHICAGO
STATE: IL
ZIP: 60606
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: STERIS plc
CENTRAL INDEX KEY: 0001624899
STANDARD INDUSTRIAL CLASSIFICATION: ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES [3842]
IRS NUMBER: 981203539
STATE OF INCORPORATION: X0
FISCAL YEAR END: 0331
BUSINESS ADDRESS:
STREET 1: RUTHERFORD HOUSE
STREET 2: STEPHENSONS WAY
CITY: DERBY
STATE: X0
ZIP: DE21 6LY
BUSINESS PHONE: (440) 354-2600
MAIL ADDRESS:
STREET 1: RUTHERFORD HOUSE
STREET 2: STEPHENSONS WAY
CITY: DERBY
STATE: X0
ZIP: DE21 6LY
FORMER COMPANY:
FORMER CONFORMED NAME: Steris plc
DATE OF NAME CHANGE: 20151102
FORMER COMPANY:
FORMER CONFORMED NAME: New STERIS Ltd
DATE OF NAME CHANGE: 20141125
FORMER COMPANY:
FORMER CONFORMED NAME: Solar New HoldCo Ltd
DATE OF NAME CHANGE: 20141112
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2019-02-20
0
0001624899
STERIS plc
STE
0001300622
Breeden Richard C
C/O RUTHERFORD HOUSE, STEPHENSONS WAY
CHADDESDEN
DERBY
X0
DE21 6LY
UNITED KINGDOM
1
0
0
0
Ordinary Shares, 10 pence par value
2019-02-20
4
M
0
3609
28.08
A
28548
D
Ordinary Shares, 10 pence par value
72242
I
See Footnote Below.
Director Stock Option (right to buy)
28.08
2019-02-20
4
M
0
3609
0.00
D
2019-07-31
Ordinary Shares
3609
0
D
Richard C. Breeden is the managing member of Breeden Capital Partners LLC, managing member and chairman and chief executive officer of Breeden Capital Management LLC. Breeden Capital Partners LLC is in turn the general partner of Breeden Partners L.P. (the "Fund").
Pursuant to Rule 16a-1(a)(2)(ii)(B) of the Securities Exchange Act of 1934, as amended, Mr. Breeden in his capacity as managing member, as well as chairman and chief executive officer of Breeden Capital Management LLC and as the managing member of Breeden Capital Partners LLC, may be deemed to be the indirect beneficial owner of the ordinary shares of STERIS plc owned by the Fund and its General Partner, and may be deemed to have beneficial ownership of all such shares.
This option to purchase 3,609 STERIS plc ordinary shares, which is fully vested, was received in conjunction with the "Combination" of STERIS Corporation and Synergy Health, Ltd. in exchange for an option to purchase 3,609 STERIS Corporation common shares for $28.08 per share, subject to the same terms and conditions as the original STERIS Corporation stock option.
/s/ Ronald E. Snyder, Authorized Representative under Power of Attorney
2019-02-21